Breast Cancer Proteomics

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Cancer Proteomics

Fig. 9.1 The histogram shows the rate of increase per year in scientific publications indexed by PubMed, regarding the most frequent types of cancer: breast, lung, prostate, colon, and thyroid…

read more

Breast Cancer Gene Therapy

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Cancer Gene Therapy

(1) Pharmaceutical Biotechnology, Faculty of Pharmacy, Anadolu University, Tepebaşı, Eskişehir, Turkey (2) Yunusemre Campus, Anadolu University, Eskişehir, Turkey (3) Anadolu University, Tepebaşı, Eskişehir, Turkey   Abstract Breast cancer, one of…

read more

Omics of Hereditary Breast Cancer

Feb 12, 2017 by in ONCOLOGY Comments Off on Omics of Hereditary Breast Cancer

Database Curator Publication Gene Expression Omnibus (GEO) National Center for Biotechnology Information (NCBI) [111] Riken Expression Array Database (READ) Riken [112] ArrayTrack U.S. Food and Drug Administration (FDA) [113] ArrayExpress…

read more

Lipidomics in Breast Cancer

Feb 12, 2017 by in ONCOLOGY Comments Off on Lipidomics in Breast Cancer

Fig. 11.1 Lipid structure representations. Examples of structures from the major classes of biological lipids (cholesterol, free fatty acid, triglyceride, phospholipid) are shown Living cells acquire fatty acids for their…

read more

Clinical Trial Endpoints in Breast Cancer

Feb 12, 2017 by in ONCOLOGY Comments Off on Clinical Trial Endpoints in Breast Cancer

Fig. 27.1 Comparison of overall survival and surrogate endpoints Disease-Free Survival (DFS) Disease-free survival (DFS) is defined as the time from randomization until recurrence of tumor or death from any…

read more

Breast Circulating Tumor Cells: Potential Biomarkers for Breast Cancer Diagnosis and Prognosis Evaluation

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Circulating Tumor Cells: Potential Biomarkers for Breast Cancer Diagnosis and Prognosis Evaluation

Fig. 21.1 Markers of breast CTCs depend on the EMT stage. MET Mesenchymal-Epithelial Transition, EMT Epithelial-Mesenchymal Transition CTCs are considered as EMT forms of primary tumor cells. Carcinoma cells initially…

read more
Get Clinical Tree app for offline access